HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IgE bullous disease.

Abstract
We report two patients with the typical picture of bullous pemphigoid who lacked two critical diagnostic immunopathological features of the disease, namely IgG or C3 bound to the epidermal basement membrane and circulating IgG antibodies directed against the basement membrane zone (BMZ). Both patients had dense infiltrates of eosinophils within their skin lesions, as well as markedly elevated serum IgE levels, while immunofluorescent studies with anti-IgE antibody revealed heavy IgE deposition on inflammatory cells within the dermis surrounding the bullae. These cells were confirmed to be eosinophils by means of specific staining with antibody to major basic protein (MBP). We speculate that this 'IgE bullous disease' resulted from IgE-mediated hypersensitivity induced by focal infection, both patients initially being helped by antibiotics. However, dramatic clearing of bullae was seen following surgical removal of a battery implant (Patient 1), and bilateral above-the-knee amputations of gangrenous legs (Patient 2).
AuthorsN Y Talanin, W B Shelley, E D Shelley
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 22 Issue 2 Pg. 82-6 (Mar 1997) ISSN: 0307-6938 [Print] England
PMID9330071 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Complement C3
  • Immunoglobulin G
  • Immunoglobulin E
Topics
  • Aged
  • Amputation, Surgical
  • Complement C3 (analysis)
  • Electric Power Supplies (adverse effects)
  • Female
  • Gangrene (complications)
  • Humans
  • Hypersensitivity, Delayed
  • Immunoglobulin E (analysis)
  • Immunoglobulin G (analysis)
  • Leg (surgery)
  • Male
  • Pemphigoid, Bullous (immunology, pathology)
  • Skin (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: